Role of Macrophage in Inflammation Resolution in Periodontal Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-08-31

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is a growing body of evidence to suggest that the resolution of an inflammatory reaction is an active process. This process requiring signals that turn off early inflammatory stages, as neutrophil infiltration and promote resolution phase, as clearance of apoptotic cells. In this array,the relationship between neutrophils, monocytes, and macrophages is crucial for the concert process.

Macrophages possess a plasticity of phenotype that explains their protective as well as potentially detrimental role in chronic inflammation and tissue injury. Such heterogeneity arises as macrophages differentiate from monocytes and are exposed to specific tissue- and hematopoietic cell-derived stimuli. It is important to be able to identify the different types of macrophages in this setting. Today's literature can distinguish between 3 main phenotypic groups of macrophages. The classically activated M1 macrophages, the alternatively activated-M2 macrophages and the "resolution phase" - rMs macrophages. The third phenotypic macrophage might play a crucial rule in the resolution phase, and is called the "resolving macrophage".

All of those pro-resolving lipid mediators promote the return to tissue homeostasis .

The investigators hypothesis is that in periodontal patients the inflammatory process continues because the process does not reach the resolution phase, and in that milieu, the macrophage might be a key component.

Within the overall concept of periodontal disease as a model for an inflammatory disease with an stoppable inflammatory reaction, the primary aim of the study is to check the macrophage characteristics in periodontal patients and to compare it to healthy people.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Effects of Immune Cells on Periodontal Healing

NCT04792372

Periodontitis

COMPLETED NA

Immunoregulation of Periodontal Diseases

NCT02567019

Parodontosis

UNKNOWN NA

White Blood Cell Signaling and Defense Mechanisms in Patients With Diabetes Mellitus Type 2 and Periodontitis

NCT01848379

Chronic Periodontitis Diabetes Mellitus, Type 2

UNKNOWN NA

Mechanisms and Treatment Response of Aggressive Periodontitis in Children

NCT01330719

Aggressive Periodontitis

COMPLETED NA

B Cell Functions in Periodontitis

NCT02833285

Chronic Periodontitis Aggressive Periodontitis

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

periodontitis

patients diagnosed with periodontal disease

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years old and more, male \& female
* generally healthy
* does not take medicine on a regular basis
* has a periodontal disease. control - without a periodontal disease
* no periodontal treatment for at list 6 months prior to his acceptance to the trail
* willing to donate 50 ml of blood twice during the trail
* understands the trail and gave a consent to participate